412 filings
Page 8 of 21
424B3
9ic7 ikm6
24 Jun 21
Prospectus supplement
4:19pm
8-K
87frnbbq4ep xw
24 Jun 21
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
qdasm2rs
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
D
x8d5u5
22 Jun 21
$39.1M in options / securities to be acquired, sold $39.1M, 12 investors
4:35pm
8-K
ia91o ibkum6fy
16 Jun 21
KemPharm Issues Letter to Shareholders
9:06am
424B3
fyhrqs0j
13 May 21
Prospectus supplement
9:11pm
424B3
ln3z5i0794 4cp
13 May 21
Prospectus supplement
4:23pm
8-K
xo3damyhad
13 May 21
KemPharm Reports First Quarter 2021 Financial Results
4:13pm
DEFA14A
ltp8l7m7zy nv
30 Apr 21
Additional proxy soliciting materials
5:24pm
424B3
tiezrv6 21gwe
8 Apr 21
Prospectus supplement
4:35pm
8-K
0v3run4
8 Apr 21
Entry into a Material Definitive Agreement
4:20pm
424B3
gqwypj
11 Mar 21
Prospectus supplement
9:56pm
8-K
yy2rj
11 Mar 21
KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Results
4:27pm
424B3
f3qon993trl0vw6xjui
3 Mar 21
Prospectus supplement
8:00am
8-K
yzhbispt8r evoea5qq
3 Mar 21
Regulation FD Disclosure
7:58am
EFFECT
ziozl5 4ov7
17 Feb 21
Notice of effectiveness
12:15am
424B5
rx9ivcn1ojpw6ij7l
16 Feb 21
Prospectus supplement for primary offering
12:00am